Printer Friendly
The Free Library
19,122,084 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

QRSCIENCES (ASX: QRS) Announce Half Year Revenue Up 247%.


Perth, Australia, Jan 12, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
 Newswire) - QRSciences (QRS QRS
A pattern seen in an electrocardiogram that indicates the pulses in a heart beat and their duration. Variations from a normal QRS pattern indicate heart disease.

Mentioned in: Bundle Branch Block
: ASX ASX

See: Australian Stock Exchange
) (QRSHY: PK), a developer of advanced sensing technologies today announced the company's half yearly revenue increased from A$ 375,000 to approximately A$ 1,300,000 (up 247%) over the corresponding period last year.

"Our expectation is that there will be a continued upward trend in revenue growth in the short to mid term, reflecting a very interesting growth stock opportunity for investors." said QRSciences CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Mr. Kevin Russeth.

This year should be a banner year for the company as its two technologies begin selling in the market. Combined with strong growth from contract R&D and consulting, on top of the synergies that the company will realise from its investment in Spectrum San Diego and its distribution relationship with XTEK, it is well positioned for solid and continued growth.

"The number one priority to grow shareholder value in 2006 is revenue," added Mr. Russeth.

"Success for us this year will be measured in the culmination and delivery of a number of proposed sales, research contracts and licensing proposals that the company is currently progressing around the world." Mr. Russeth concluded.

About QRSciences

QRSciences is a developer of advanced technology and leader in QR, an emerging explosive detection technology that uses radio frequency spectroscopy techniques to detect and positively identify a wide range of difficult to detect explosives. Applications include explosive and narcotic narcotic, any of a number of substances that have a depressant effect on the nervous system. The chief narcotic drugs are opium, its constituents morphine and codeine, and the morphine derivative heroin.

See also drug addiction and drug abuse.
 detection, pharmaceutical quality control and assurance, mineral and material assay, lab instrumentation and environmental science. In September, 2005, QXR 1000, incorporating Rapiscan's X-ray system and QRSciences' proprietary hardware and software was presented before the United States House Committee on Homeland Security The U.S. House Committee on Homeland Security is a standing committee of the United States House of Representatives, the lower house of Congress. Its responsibilities include U.S. security legislation and oversight of the Department of Homeland Security.  by its development and manufacturing partner OSI Systems. QRSciences is headquartered in Perth, Western Australia This article is about the metropolitan area of Perth, Western Australia. For the local government area, see City of Perth.
Perth is the capital of the Australian state of Western Australia.
 with a wholly-owned subsidiary, QRSciences Corporation, based in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation).
San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951.
. For more information, please visit www.qrsciences.com.

Source: QRSciences

Contact:
Jennifer Zimmons
Strategic Growth
New York, N.Y.
Tel: +1(212)838-1444

Warrick Hazeldine
Purple Communications
Perth, Australia
Tel: + 61 (0) 8 9485 1254
Mob: +61 (0) 417 944 616

Kevin Russeth
QRSciences
San Diego, CA
Tel: +1(858)345-1095
Australia: +61 (0) 8 9351 1200


Copyright [c] 2006 JCN Newswire. All rights reserved. A division of Japan Corporate News Network K.K.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCN Newswires
Date:Jan 12, 2006
Words:374
Previous Article:Fujitsu to Construct New Fab for Logic Chips Employing 65nm Process Technology and 300mm Wafers.
Next Article:Sanix Announces Monthly Consolidated Sales Volume for December 2005.



Related Articles
Mergers of entities and nonentities: the shape of things to come?
QRS newest tenant in Lincoln Building.
Racial differences in echocardiographic and electrocardiographic parameters in an indigent and ethnically diverse population.
Ejection fraction and QRS width as predictors of event rates in patients with implantable cardioverter defibrillators.
SAI Global Limited (ASX: SAI) Reports Strong Growth.
Osborn waves in sepsis.
Questioning Guidelines in the ECG Puzzler.
Evaluating pacemaker function with full disclosure.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles